Company name
2022Founder
Morgan Cheatham, MD leads healthcare and life sciences investing at Breyer Capital, where he works with companies and founders at the intersection of computation, precision medicine, and prevention. He trained in computational decision sciences and medicine at Brown University and writes about healthcare innovation, including the role of AI and new business models in translating biomedical research into care.
Partner and Head of Healthcare and Life Sciences
B.S. in Computational Decision Sciences
M.D.